Showing 1 - 10 of 10
A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal...
Persistent link: https://www.econbiz.de/10005341686
The paper analyzes the determinants of internationalisation, defined in terms of export intensity and overseas investments, of the IT firms in India. In particular, the paper examines the role of technology sourcing, both internal (in-house R&D) and external (technology imports), in determining...
Persistent link: https://www.econbiz.de/10005341763
Tomotaoes which are produced in Gujarat, north west India are small, so the growers were not organized enough to raise funds to sponsor research at public R&D institutions in the area. That task was therefore taken up. Boxes that protected the produce better on long journey and were affordable...
Persistent link: https://www.econbiz.de/10005341791
In this context, higher education as well as research and development (R&D) have long since ceased to be purely the domain of the developed Western economies. Numerous regions of the world, some in the emerging markets in particular – the often-cited BRIC countries – are catching...
Persistent link: https://www.econbiz.de/10009653328
How does innovation impact on development? How, and under what conditions, do entrepreneurs in developing countries innovate? And what can be done to support innovation by entrepreneurs in developing countries? This policy brief addresses these questions and explains the relationship between...
Persistent link: https://www.econbiz.de/10009323949
The paper seeks to prove the point that the Indian OTC derivatives markets, unlike many other jurisdictions, are well regulated. Only contracts where one party to the contract is an RBI regulated entity are considered legally valid in India. A good reporting system and a post-trade clearing and...
Persistent link: https://www.econbiz.de/10008509776
The pharmaceutical industry is expanding worldwide. For some years now, it has been benefiting from the particular dynamics of the Asian economies as both purchasers and producers. It is not only the markets in China and India that register high growth rates. Despite the positive outlook India...
Persistent link: https://www.econbiz.de/10005170195
Three important aspects of the Canadian pharmaceutical industry-viz. compulsory licence, price control on patented drugs and the R&D scenario. Unlike other developed countries, which have adopted the route of providing higher Intellectual Property Rights (IPR) protection to promote the growth of...
Persistent link: https://www.econbiz.de/10005487733
This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs,and the future returns to research and development (R&D). While there still remains an abundance of...
Persistent link: https://www.econbiz.de/10005487741
This report reviews the input and output policies for cereals implemented in Pakistan during the period 1996–2010. Pakistan has a long and varied history of intervening in farm input and output markets, going back decades before the period under review. [IFPRI Discussion Paper 01223]....
Persistent link: https://www.econbiz.de/10011133189